These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26204584)

  • 1. How Bioethics is Complementing Human Rights in Realizing Health Access for Clinical Trial Participants: The Case of Formative PrEP Access in South Africa.
    Singh J
    Health Hum Rights; 2015 Jun; 17(1):E58-62. PubMed ID: 26204584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Human Rights Case Study on Access to Pre-exposure Prophylaxis for Female Sex Workers in South Africa.
    Winkelman S
    Health Hum Rights; 2022 Jun; 24(1):105-115. PubMed ID: 35747274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. South Africa: highest court orders government to provide antiretrovirals to prevent mother-to-child transmission.
    Gerntholtz L
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):50-2. PubMed ID: 14725243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in HIV vaccine trials in South Africa.
    Slack C; Lindegger G; Vardas E; Richter L; Strode A; Wassenaar D
    S Afr J Sci; 2000 Jun; 96():291-5. PubMed ID: 11863014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mind the gap: An empirical study of post-trial access in HIV biomedical prevention trials.
    Haire B; Jordens C
    Dev World Bioeth; 2015 Aug; 15(2):85-97. PubMed ID: 26193849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial.
    Mansoor LE; Abdool Karim Q; Mngadi KT; Dlamini S; Montague C; Nkomonde N; Mvandaba N; Baxter C; Gengiah TN; Samsunder N; Dawood H; Grobler A; Frohlich JA; Abdool Karim SS
    Trials; 2014 Dec; 15():496. PubMed ID: 25527071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The right to health and the nevirapine case in South Africa.
    Annas GJ
    N Engl J Med; 2003 Feb; 348(8):750-4. PubMed ID: 12594322
    [No Abstract]   [Full Text] [Related]  

  • 8. Impeding access? Stigma, individual responsibility and access to post-HIV-exposure prophylaxis (PEP) in South Africa.
    Pieterse M
    Med Law; 2011 Jun; 30(2):279-94. PubMed ID: 21877471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal HIV screening and treatment in South Africa: social norms and policy options.
    Hasnain M
    Afr J Reprod Health; 2004 Aug; 8(2):77-85. PubMed ID: 15623122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Because we can: clashes of perspective over researcher obligation in the failed PrEP trials.
    Haire BG
    Dev World Bioeth; 2011 Aug; 11(2):63-74. PubMed ID: 21266000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
    Haire B; Kaldor JM
    Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saying 'No' to PrEP research in Malawi: what constitutes 'failure' in offshored HIV prevention research?
    Peterson K; Folayan MO; Chigwedere E; Nthete E
    Anthropol Med; 2015 Dec; 22(3):278-94. PubMed ID: 26422196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 15. Health, Human Rights, and the Transformation of Punishment: South African Litigation to Address HIV and Tuberculosis in Prisons.
    Keehn EN; Nevin A
    Health Hum Rights; 2018 Jun; 20(1):213-224. PubMed ID: 30008564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring perceptions of HIV risk and health service access among Zimbabwean migrant women in Johannesburg: a gap in health policy in South Africa?
    Munyewende P; Rispel LC; Harris B; Chersich M
    J Public Health Policy; 2011; 32 Suppl 1():S152-61. PubMed ID: 21730988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating sexual and reproductive health and rights and HIV/AIDS in South Africa.
    de Vos M
    HIV AIDS Policy Law Rev; 2010 Oct; 15(1):52-3. PubMed ID: 21413629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of civil society in health policy making in South Africa: a review of the strategies adopted by the Treatment Action Campaign.
    Sabi SC; Rieker M
    Afr J AIDS Res; 2017 Mar; 16(1):57-64. PubMed ID: 28367744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.